Why Did iTeos Therapeutics Plunge 12.13%?

On April 3, 2025, iTeos Therapeutics experienced a significant drop of 12.13% in pre-market trading, indicating a bearish sentiment among investors.

iTeos Therapeutics has been facing sell signals from both short and long-term moving averages, contributing to a more negative outlook for the stock. This technical analysis suggests that the stock may continue to decline in the near future.

Additionally, the company's MarketRank™ score, which evaluates its performance relative to other companies in the medical sector, has been lower than expected. This ranking indicates that iTeos Therapeutics is underperforming compared to its peers, which could further dampen investor confidence.

Overall, the combination of technical sell signals and a lower MarketRank™ score has led to a significant decline in iTeos Therapeutics' stock price, reflecting the current market sentiment towards the company.